Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesRetained EarningsShareholder's EquityTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

FS Specialty Lending Fund (FSEN) Cash & Equivalents (2022 - 2025)

FS Specialty Lending Fund's Cash & Equivalents history spans 4 years, with the latest figure at $232.9 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 26.3% year-over-year to $232.9 million; the TTM value through Jun 2025 reached $232.9 million, down 26.3%, while the annual FY2024 figure was $202.1 million, 58.42% down from the prior year.
  • Cash & Equivalents reached $232.9 million in Q2 2025 per FSEN's latest filing, up from $95.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $486.1 million in Q4 2023 to a low of $95.0 million in Q1 2025.
  • Average Cash & Equivalents over 4 years is $280.6 million, with a median of $235.1 million recorded in 2024.
  • Peak YoY movement for Cash & Equivalents: grew 0.91% in 2023, then crashed 58.42% in 2024.
  • A 4-year view of Cash & Equivalents shows it stood at $481.7 million in 2022, then increased by 0.91% to $486.1 million in 2023, then plummeted by 58.42% to $202.1 million in 2024, then increased by 15.25% to $232.9 million in 2025.
  • Per Business Quant, the three most recent readings for FSEN's Cash & Equivalents are $232.9 million (Q2 2025), $95.0 million (Q1 2025), and $202.1 million (Q4 2024).